RECHEM
Welcome to our website!|Hot Line: 86-21-61417495|E-mail: sales@rechemscience.com
Products Category
Contact Us
Tel: +86-21-61417495
Fax: +86-21-61417495
Email: sales@rechemscience.com
  info@rechemscience.com
QQ: 1369748377
Skype: sales@rechemscience.com
Home > Products > Epigenetics
Cat.No. Product name Product Description
R10008 Rucaparib phosphate; AG014699; PF01367388 Rucaparib (AG-014699, PF-01367338) is an inhibitor of PARP with Ki of 1.4 nM for
R10010 Rucaparib; AG-014699; PF-01367388 Rucaparib (AG-014699, PF-01367338) is an inhibitor of PARP with Ki of 1.4 nM for
R10015 MN-64 MN-64 is a inhibitor of tankyrases, showed 6 nM potency against tankyrase 1, iso
R10023 ACY-1215 Rocilinostat (ACY-1215) is a selective HDAC6 inhibitor with IC50 of 5 nM in a ce
R10026 Ruxolitinib (INCB018424) CAS NO.:941678-49-5Product Name:β-Cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl
R10033 MLN8237 Alisertib (MLN8237) is a selective Aurora A inhibitor with IC50 of 1.2 nM in a c
R10034 MK8745 MK-8745 is a potent and selective Aurora A inhibitor with IC50 of 0.6 nM, more t
R10056 Tubastatin-A Tubastatin A is a potent and selective HDAC6 inhibitor withIC50 of 15 nM in a ce
R10071 SRT1720 SRT1720 is a selective SIRT1 activator with EC50 of 0.16 μM in a cell-free assay
R10096 IOX2 IOX2 is a potent inhibitor of HIF-1α prolyl hydroxylase-2 (PHD2) with IC50 of 21
R10104 PF03814735 PF-03814735 is a novel, potent and reversible inhibitor of Aurora A/B with IC50o
R10106 MS275 Entinostat (MS-275) strongly inhibits HDAC1 and HDAC3 with IC50 of 0.51 μM and 1
R10108 KU0059436; AZD2281; Olaparib Olaparib (AZD2281, KU0059436) is a selective inhibitor of PARP1/2 with IC50 of 5
R10130 VX680; MK0457; Tozasertib VX-680 (Tozasertib, MK-0457) is a pan-Aurora inhibitor, mostly against Aurora A
R10131 CYT387 Momelotinib (CYT387) is an ATP-competitive inhibitor of JAK1/JAK2 with IC50 of 1
R10153 FG4592 Roxadustat (FG-4592) is an HIF α prolyl hydroxylase inhibitor in a cell-free ass
R10179 4SC201 Resminostat dose-dependently and selectively inhibits HDAC1/3/6 with IC50 of 42.
R10191 CI994 CI994 (Tacedinaline) is an anti-cancer drug which inhibits HDAC1 with IC50 of 0.
R10213 SGI1776 SGI-1776 free base is a novel ATP competitive inhibitor of Pim1 with IC50 of 7 n
R10220 WP1066 WP1066 is a novel inhibitor of JAK2 and STAT3 with IC50 of 2.30 μM and 2.43 μM i
R10223 GSK503 GSK503 is a potent and specific EZH2 methyltransferase inhibitor.
R10224 Sirtinol Sirtinol is a specific SIRT1 and SIRT2 inhibitor with IC50 of 131 μM and 38 μM i
R10232 PCI24781 PCI-24781 (Abexinostat; CRA 24781) is a novel pan-HDAC inhibitor mostly targetin
R10236 BMN673 Talazoparib (BMN 673) is a novel PARP inhibitor with IC50 of 0.58 nM in a cell-f
R10237 MGCD0103 Mocetinostat (MGCD0103) is a potent HDAC inhibitor with most potency for HDAC1 w
Page 1 / Total 4 FirstPrevNextLastGoto